dr. graff on extended adjuvant therapy in early-stage hr breast cancer
Published 4 years ago • 195 plays • Length 1:18Download video MP4
Download video MP3
Similar videos
-
0:52
dr. graff on genomic risk prediction in hr /her2- breast cancer
-
6:55
extended adjuvant therapy for her2 early breast cancer
-
1:46
dr. graff on novel therapies in metastatic breast cancer
-
1:01
dr. graff on the use of sacituzumab govitecan in breast cancer
-
1:53
dr. tolaney on navigating adjuvant therapy in early-stage her2 breast cancer
-
1:05:31
adjuvant therapy for early-stage her2-positive breast cancer
-
10:02
breast cancer: extended adjuvant endocrine therapy
-
0:52
dr. graff on future research with immunotherapy in breast cancer
-
8:21
extended adjuvant therapy for her2-positive breast cancer
-
8:26
adjuvant strategies in early-stage her2 breast cancer
-
1:12
dr. graff underscores unmet needs in esr1-mutated breast cancer
-
2:51
breast cancer: extended adjuvant therapy and cost factors
-
5:49
clinical data on extended adjuvant therapy in hr bc
-
1:24
dr. rugo on extended adjuvant hormone therapy for breast cancer
-
1:01
dr. graff on current treatments in esr1-mutant breast cancer
-
0:59
dr. graff discusses optimal dosing of tamoxifen in breast cancer
-
3:58
post-adjuvant therapy for her2 breast cancer
-
0:22
copy of dr. graff on the use of sacituzumab govitecan in breast cancer
-
20:25
her2 early-stage breast cancer: peri-operative therapy